13.23
price down icon0.08%   -0.010
pre-market  Vorhandelsmarkt:  13.30   0.07   +0.53%
loading

Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten

pulisher
Dec 09, 2025

Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? - Yahoo Finance UK

Dec 09, 2025
pulisher
Dec 09, 2025

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Amylyx Pharmaceuticals Inc (AMLX) Receives a Buy from Mizuho Securities - The Globe and Mail

Dec 09, 2025
pulisher
Dec 08, 2025

Amylyx presents safety outcomes of AMX0114 in LUMINA study - Yahoo

Dec 08, 2025
pulisher
Dec 06, 2025

Amylyx’s ALS drug AMX0114 shows positive early safety data By Investing.com - Investing.com Nigeria

Dec 06, 2025
pulisher
Dec 06, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

Presentation at MNDA: Characterizing the CSF Biomarker Signature of Calpain-2 Activity in ALS and Its Application in the Phase 1 LUMINA Trial (dae63b) - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Amylyx’s ALS drug AMX0114 shows positive early safety data - Investing.com

Dec 05, 2025
pulisher
Dec 05, 2025

Amylyx Pharmaceuticals announces new safety and tolerability cohort 1 data of amx0114 - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial - Business Wire

Dec 05, 2025
pulisher
Dec 05, 2025

Amylyx Pharmaceuticals, Inc. $AMLX Stock Position Increased by Saturn V Capital Management LP - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Amylyx Pharmaceuticals, Inc. $AMLX Stock Position Lifted by Alpha Wave Global LP - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Can Amylyx Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Camille Bedrosian Sells 6,580 Shares of Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Geode Capital Management LLC Acquires 886,252 Shares of Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

Top Executive Makes Significant Stock Sale at Amylyx Pharmaceuticals - TipRanks

Dec 03, 2025
pulisher
Dec 03, 2025

Transcript : Amylyx Pharmaceuticals, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 04 - marketscreener.com

Dec 03, 2025
pulisher
Dec 03, 2025

Amylyx Pharmaceuticals CMO Sells Shares to Cover Tax Obligations - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

Officer Bedrosian Surrenders 6,580 Of Amylyx Pharmaceuticals Inc [AMLX] - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? - Yahoo Finance

Dec 03, 2025
pulisher
Dec 02, 2025

Key facts: Amylyx nears phase III trial for Avexitide; Bedrosian to sell shares - TradingView

Dec 02, 2025
pulisher
Dec 01, 2025

Officer Bedrosian Files To Sell 6,580 Of Amylyx Pharmaceuticals Inc [AMLX] - TradingView

Dec 01, 2025
pulisher
Nov 29, 2025

Amylyx Pharmaceuticals' co-CEO Justin Klee sells $41,103 in shares - MSN

Nov 29, 2025
pulisher
Nov 29, 2025

RSI Check: Will Amylyx Pharmaceuticals Inc. stock benefit from sector rotationJuly 2025 Patterns & High Conviction Investment Ideas - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - marketscreener.com

Nov 28, 2025
pulisher
Nov 28, 2025

How Amylyx Pharmaceuticals Inc. stock trades before earningsPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn

Nov 28, 2025
pulisher
Nov 27, 2025

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead - AOL.com

Nov 27, 2025
pulisher
Nov 27, 2025

Kennondale Capital Management LLC Has $610,000 Stake in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

17,551 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Acquired by ProShare Advisors LLC - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Amylyx Pharmaceuticals Reports Strong Q3 2025 Results - MSN

Nov 25, 2025
pulisher
Nov 21, 2025

Amylyx Pharmaceuticals Inc. (AMLX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

How sustainable is Amylyx Pharmaceuticals Inc. stock dividend payoutWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Amylyx Pharmaceuticals Inc. stock positioned for digital transformationWeekly Stock Recap & Consistent Growth Stock Picks - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Can Amylyx Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Amylyx Pharmaceuticals Inc. stock attractive for growth ETFsOil Prices & Weekly Watchlist for Consistent Profits - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What the charts say about Amylyx Pharmaceuticals Inc. today2025 Year in Review & Stepwise Trade Signal Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceGap Up & Weekly Return Optimization Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Real time social sentiment graph for Amylyx Pharmaceuticals Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Los Angeles Capital Management LLC Takes $149,000 Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat

Nov 19, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):